HUMAN Diagnostics has successfully revamped its urinalysis portfolio - portable on-the-spot testing now easier and more precise than ever before

Wiesbaden, Germany - March 26, 2025 - HUMAN Diagnostics is proud to announce the successful relaunch of its urinalysis portfolio, unveiled during Medlab Middle East 2025 in Dubai from February 3-6. The overhaul includes the introduction of cutting-edge solutions designed to transform urinalysis diagnostics with a focus on precision, efficiency, and accessibility.

Highlights include the innovative HumaCombilyzer, a portable, semi-automated urine strip analyzer, and the HumaVision, a state-of-the-art automated urine particle analyzer that uses artificial intelligence (AI) and Digital Holographic Microscopy (DHM). These advancements enable faster, more accurate diagnostics in a wide range of healthcare settings.

"Urinalysis is a fundamental diagnostic tool, and with our restructured portfolio, HUMAN is setting a new standard for efficiency and accuracy in this vital field," said Dr. Christine Hettmann-Dreuw, VP Marketing & Strategic Purchase at HUMAN Diagnostics. "By integrating advanced AI and user-friendly designs, we are enhancing workflows while maintaining our commitment to providing solutions that are accessible worldwide."

Key Features of the New Portfolio:
• HumaCombilyzer: A versatile urine test strip analyzer offering rapid results for up to 14 parameters, ideal for both small clinics and mobile healthcare environments. Its portability and intuitive interface make it particularly suited for resource-limited settings.

• HumaVision - the smallest, most comfortable urine microscope on the market: Powered by DHM and AI, this analyzer delivers precise and fully digitalized urine particle analysis in just 3-7 minutes, eliminating the need for complex sample preparation. It ensures a larger field of view and more reliable results compared to manual microscopy.

The updated portfolio is designed to address diverse diagnostic needs, from detecting urinary tract infections and kidney conditions to identifying metabolic disorders such as diabetes and liver diseases. By automating key processes, the instruments significantly reduce human error, optimize workflows, and enhance diagnostic confidence.

Medlab ME 2025 attendees experienced firsthand how HUMAN Diagnostics is driving innovation in urinalysis. Demonstrations at the HUMAN booth showcased the practical benefits of these new solutions, emphasizing their role in improving diagnostic workflows and patient outcomes globally.

HUMAN Diagnostics remains committed to supporting healthcare professionals in over 160 countries with high-quality, German-engineered solutions that enhance equitable access to life-saving diagnostics.

For more information about the new urinalysis portfolio, download the product flyer at https://bit.ly/4hvVWmk

Media Contact:
Thomas Koenig
Sr. Manager Marketing Communications & PR
HUMAN Diagnostics
t.koenig@human.de
+49 6122 9988 167

HUMAN Diagnostics is a global provider of in vitro diagnostic solutions, serving laboratories and healthcare providers in over 160 countries. Headquartered in Wiesbaden, Germany, HUMAN offers a comprehensive portfolio of products designed to enhance diagnostic capabilities and support better patient outcomes.

This release was published on openPR.